About Instituto do Câncer do Estado de São Paulo - ICESP, Núcleo de Pesquisa
Instituto do Câncer de São Paulo Octavio Frias de Oliveira é um centro de atendimento médico e hospitalar que funciona como autarquia vinculada ao Governo do Estado de São Paulo.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Institut de Recherches Internationales Servier
2
Clinical Trials at Instituto do Câncer do Estado de São Paulo - ICESP, Núcleo de Pesquisa
During the past decade, Instituto do Câncer do Estado de São Paulo - ICESP, Núcleo de Pesquisa conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study Evaluating S 95005 Plus Bevacizumab and Capecitabine Plus Bevacizumab in Patients With Previously Untreated Colorectal Cancer Who Are Non-eligible for Intensive Therapy
2016-04-29
2020-09-01
Completed
154
A Study of Trifluridine/Tipiracil (Also Known as S 95005 or TAS-102) in Patients With a Pretreated Colorectal Cancer That Has Spread (Metastatic).
2016-10-18
2020-11-30
Completed
907
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Instituto do Câncer do Estado de São Paulo - ICESP, Núcleo de Pesquisa"
#1 collaborator was "ADIR, a Servier Group company" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Instituto do Câncer do Estado de São Paulo - ICESP, Núcleo de Pesquisa
According to Clinical.Site data, the most researched conditions in "Instituto do Câncer do Estado de São Paulo - ICESP, Núcleo de Pesquisa" are
"Metastatic Colorectal Cancer" (2 trials). Many other conditions were trialed in "Instituto do Câncer do Estado de São Paulo - ICESP, Núcleo de Pesquisa" in a lesser frequency.
Clinical Trials Intervention Types at Instituto do Câncer do Estado de São Paulo - ICESP, Núcleo de Pesquisa
Most popular intervention types in "Instituto do Câncer do Estado de São Paulo - ICESP, Núcleo de Pesquisa" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Capecitabine + bevacizumab" (1 trials), "Trifluridine/Tipiracil hydrochloride (S95005)" (1 trials) and "Trifluridine/tipiracil + bevacizumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Instituto do Câncer do Estado de São Paulo - ICESP, Núcleo de Pesquisa
The vast majority of trials in "Instituto do Câncer do Estado de São Paulo - ICESP, Núcleo de Pesquisa" are
2 trials for "All" genders.
Clinical Trials Status at Instituto do Câncer do Estado de São Paulo - ICESP, Núcleo de Pesquisa
Currently, there are NaN active trials in "Instituto do Câncer do Estado de São Paulo - ICESP, Núcleo de Pesquisa".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Instituto do Câncer do Estado de São Paulo - ICESP, Núcleo de Pesquisa,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Instituto do Câncer do Estado de São Paulo - ICESP, Núcleo de Pesquisa, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".